Release Date: 10/03/10 09:57 Summary: SBN to undertake SPP Price Sensitive: Yes Download Document 120.14KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%